Biblio Discovery — Demo Discovery Service

47 hasil untuk "Christian Vestergaard"

Menampilkan 1–20 · 0,42 detik · RSS

  1. Artikel Jurnal

    Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature

    Rikke Bech; Line Kibsgaard; Christian Vestergaard

    Frontiers in Medicine, Vol. 5 · 2018 · Inggris · DOAJ Scopus

    Bullous Pemphigoid is an autoimmune skin blistering disease. It is caused by deposition of auto antibodies along the dermal-epidermal border leading to inflammation. The antibodies are directed against anchoring filaments in the epidermis, but these antigens are also present in the neurological…

  2. Artikel Jurnal

    Disease Mechanisms in Atopic Dermatitis: A Review of Aetiological Factors

    Jacob P. Thyssen; Maria Rasmussen Rinnov; Christian Vestergaard

    Acta Dermato-Venereologica, Vol. 100 No. 12 · 2020 · Inggris · DOAJ Scopus

    Atopic dermatitis is a prevalent inflammatory skin condition characterized by itch and dry skin, which affects 15–20% of children and 3–5% of adults. This article reviews epidemiological, clinical and experimental data to provide an overview of the most important disease mechanisms in atopic…

  3. Artikel Jurnal

    Assessment of Quality and Utility of Patient-Taken Smartphone Photographs of Atopic Dermatitis: Clinical Survey Study

    Zarqa Ali; Kenneth Thomsen; Christian Vestergaard dkk.

    JMIR Dermatology, Vol. 9 · 2026 · Inggris · DOAJ Scopus

    Abstract BackgroundAtopic dermatitis (AD) has a relapsing and remitting nature, and scheduled clinic visits only provide a snapshot of the skin condition at the moment. ObjectiveThis study aimed to investigate the quality of patient-taken smartphone photographs of AD skin lesions and characterize…

  4. Artikel Jurnal

    Recurrence Rates in Paediatric Patients With Atopic Dermatitis: A Comparison Between Topical and Systemic Treatments

    Frederikke Seeberg; Anne Sofie Frølunde; Mette Deleuran dkk.

    JEADV Clinical Practice, Vol. 5 No. 1 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Background Atopic dermatitis (AD) is a chronic, relapsing skin condition that significantly affects children and their families. Treatment ranges from topical to systemic therapies, but evidence on long‐term recurrence following different treatment strategies in paediatric AD remains…

  5. Artikel Jurnal

    Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study

    Misbah Noshela Ghazanfar; Line Kibsgaard; Simon Francis Thomsen dkk.

    World Allergy Organization Journal, Vol. 13 No. 1 · 2020 · Inggris · DOAJ Scopus

    Background: The autoimmune profile of Chronic Urticaria (CU) patients is an increasing topic of interest. Associated diseases suggest shared pathogenic pathways, and they may provide important knowledge on specific targets for future treatment models. In this study we examined the prevalence and…

  6. Artikel Jurnal

    The doctors' perception of skin diseases in general practice in Denmark, with emphasis on atopic dermatitis: A descriptive study

    Anne Sofie Froelunde; Mette Deleuran; Janus L. Thomsen dkk.

    JEADV Clinical Practice, Vol. 3 No. 4 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Skin symptoms are a common reason for consulting a medical doctor, for example a general practitioner (GP) in countries where GPs function as gatekeepers. Despite this, GPs have very sparse dermatological training in their Residency programme. Objectives To investigate…

  7. Artikel Jurnal

    Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports

    Kenneth Thomsen; Jon Diernaes; Trine Heide Øllegaard dkk.

    Case Reports in Dermatology, Vol. 10 No. 2 · 2018 · Inggris · DOAJ Scopus

    Checkpoint inhibitors are novel and promising treatment options for different types of cancer. Programmed cell death 1 (PD-1) inhibitors, such as pembrolizumab, have been shown to significantly raise the survival rates of disseminated malignant melanoma (MM). Autoimmune adverse reactions are very…

  8. Artikel Jurnal

    Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid

    Inger Johanne Fenne; Guro Askildsen Oftebro; Christian Vestergaard dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    IntroductionBullous pemphigoid (BP) can be treated using systemic and topical glucocorticoids and/or other immunomodulatory agents. However, the long-term use of systemic glucocorticoids causes severe adverse side effects. This study was aimed at investigating whether the early initiation of…

  9. Artikel Jurnal

    Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic Glucocorticoid

    Kenneth Thomsen; Mette Deleuran; Christian Vestergaard dkk.

    Case Reports in Dermatology, Vol. 11 No. 2 · 2019 · Inggris · DOAJ Scopus

    We present a case of severe and treatment-refractory bullous pemphigoid in a 3-month-old child. After topical and systemic corticoid treatment proved inefficient, dapsone 0.75 mg/kg was added initially without success. Disease control was reached with dapsone 1.5 mg/kg in addition to both topical…

  10. Artikel Jurnal

    Eleven Danish patients diagnosed with Scabies and treated with Tenutex®

    Christian A. S. Soerensen; Kristine Appel Uldall Pallesen; Nadja Trier Munk dkk.

    Clinical Case Reports, Vol. 9 No. 3 · 2021 · Inggris · DOAJ Dikeluarkan Scopus 2021

    Abstract Treatment with Tenutex® should be considered in patients diagnosed with scabies if the first‐line treatment with 5% permethrin fails. Treatment failure with 5% permethrin may be due to tolerance or resistance in scabies mites.

  11. Artikel Jurnal

    A safety checklist before initiating second-generation immunomodulating drugs for inflammatory dermatoses: a systematic review

    Stine R. Haysen; Lykke Skaarup; Simon Poulsen dkk.

    Journal of Dermatological Treatment, Vol. 37 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background/Aim Second-generation immunomodulating drugs for inflammatory dermatoses have expanded over the past decades. Contraindications and special warnings must be considered before starting any treatment, but identifying all relevant safety information can be time-consuming. The objective is…

  12. Artikel Jurnal

    Treatment and referral patterns of patients with atopic dermatitis from the Danish primary care system to the tertiary care system

    Anna Kathrine Danielsen; Anne Sofie Frølunde; Sofine Heilskov dkk.

    JEADV Clinical Practice, Vol. 3 No. 4 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Patients with atopic dermatitis (AD) are mostly managed by general practitioners (GPs) and practicing dermatologists (PDs) in Denmark. In cases of severe and refractory AD, the primary physician can refer the patient to a specialised dermatology department. Objectives Aim of the…

  13. Artikel Jurnal

    Can Foot Dermatophyte Infections Signal Future Diabetes Risk? Findings from a Register-based Study

    Anne Sofie Frølunde; Jan Brink Valentin; Lise Kristensen dkk.

    Acta Dermato-Venereologica, Vol. 106 · 2026 · Inggris · DOAJ Scopus

    Dermatophyte infections are common in general practice and occur more often in individuals with type 2 diabetes (T2D), but whether they signal undiagnosed T2D remains unclear. We conducted a register-based cohort study including positive PCR tests for dermatophyte infection from the feet or nails…

  14. Artikel Jurnal

    Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment

    Catalina H. Skovsgård; Anne Sofie Frølunde; Mette Deleuran dkk.

    Acta Dermato-Venereologica, Vol. 105 · 2025 · Inggris · DOAJ Scopus

    Atopic dermatitis (AD) is a common inflammatory skin disease affecting 5–8% of adults, with many being of reproductive age and potentially experiencing AD- and treatment-related challenges during family planning and pregnancy (FPP). This study examined whether patients with AD receive FPP-related…

  15. Artikel Jurnal

    Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood: A Danish Register-based Study

    Jacob P. Thyssen; Andreas W. Brenneche; Maria E. Madsen dkk.

    Acta Dermato-Venereologica, Vol. 101 No. 9 · 2021 · Inggris · DOAJ Scopus

    To estimate the cost of illness in adult patients with moderate-to-severe atopic dermatitis (AD) a cohort study was conducted identifying Danish citizens (≥ 18 years) diagnosed with AD between 1997 and 2018 in the Danish National Patient Register. Moderate-to-severe AD was defined as ≥3 hospital…

  16. Artikel Jurnal

    Identifying Mild-to-Moderate Atopic Dermatitis Using a Generic Machine Learning Approach: A Danish National Health Register Study

    Mie Sylow Liljendahl; Kristina Ibler; Christian Vestergaard dkk.

    Acta Dermato-Venereologica, Vol. 105 · 2025 · Inggris · DOAJ Scopus

    Atopic dermatitis is a chronic skin disease, causing itching and recurrent eczematous lesions. In Danish national register data, adults with atopic dermatitis can only be identified if they have a hospital-diagnosed atopic dermatitis. The purpose of this study was to develop a machine learning…

  17. Artikel Jurnal

    Maintained improvement of outcomes related to skin clearance, itch, sleep and quality of life with baricitinib in adults with moderate-to-severe Atopic Dermatitis who were treated for up to 200 weeks in a randomized trial

    Andreas Wollenberg; Antonio Costanzo; Christian Vestergaard dkk.

    Journal of Dermatological Treatment, Vol. 36 No. 1 · 2025 · Inggris · DOAJ Scopus

    Objective To report response maintenance in patients with moderate-to-severe Atopic Dermatitis (AD) upon continuous or downtitrated baricitinib treatment for 200 weeks.Methods Patients with vIGA-AD® (validated Investigator Global Assessment for Atopic Dermatitis) score ≤2 at Week 52 treated with…